Advertisement

Medical Oncology

, Volume 27, Issue 3, pp 685–689 | Cite as

Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance

  • Yuanyuan Zhang
  • Junming Guo
  • Dong Li
  • Bingxiu Xiao
  • Ying Miao
  • Zhen Jiang
  • Hui Zhuo
Original Paper

Abstract

MicroRNAs (miRNAs) are non-coding RNAs that regulate the expression of target mRNAs. Altered expression of specific miRNAs in several tumor types has been reported. However, the expression levels of miR-31 in gastric cancers are unclear. The objective of the present study was to compare the expression profile of miR-31 between gastric cancer tissues and non-tumor tissues. Real-time quantitative reverse transcription-polymerase chain reaction technology was used to detect the levels of miR-31 expression. The expression levels of miR-31 in gastric cancer tissues were significantly lower than those in non-tumor tissues. This new information may help to clarify the molecular mechanisms involved in gastric carcinogenesis and to indicate that miR-31 may be a novel diagnostic biomarker of gastric cancer.

Keywords

MicroRNA-31 Gastric cancer Gene expression Gene diagnosis 

Notes

Acknowledgments

This work was supported by Scientific Research Fund of Zhejiang Provincial Education Department (No. 20070965), Student Innovation and Open Laboratory Program of Ningbo University (No. Cxxkf 2008-067), Ningbo Natural Science Foundation (No. 2009A610134), Zhejiang Province Research Project (No. 2008C33020, and No. 2008F70052), Zhejiang Natural Sciences Foundation (No. Y207240 and No. Y207244), National Natural Science Foundation of China (No. 30872420), and K. C. Wong Magna Fund in Ningbo University.

References

  1. 1.
    Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349:1498–504.CrossRefPubMedGoogle Scholar
  3. 3.
    Gaspar MJ, Arribas I, Coca MC, Diez-Alonso M. Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma. Tumour Biol. 2001;22:318–22.CrossRefPubMedGoogle Scholar
  4. 4.
    Marrelli D, et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology. 1999;57:55–62.CrossRefPubMedGoogle Scholar
  5. 5.
    Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Haglund C. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22:2311–6.PubMedGoogle Scholar
  6. 6.
    Takahashi Y, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer. 2003;6:142–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Hatfield S, Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res. 2008;331:57–66.CrossRefPubMedGoogle Scholar
  8. 8.
    Calin GA, Croce CM. MicroRNA-cancer connection: ‘the beginning of a new tale’. Cancer Res. 2006;66:7390–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Volinia S, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257–61.CrossRefPubMedGoogle Scholar
  10. 10.
    Bandrés E, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer. 2006;5:29.CrossRefPubMedGoogle Scholar
  11. 11.
    Chan SH, Wu CW, Li AF, Chi CW, Lin WC. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res. 2008;28:907–11.PubMedGoogle Scholar
  12. 12.
    Zhang HH, Wang XJ, Li GX, Yang E, Yang NM. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol. 2007;13:2883–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Ji Q, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008;8:266.CrossRefPubMedGoogle Scholar
  14. 14.
    Guo J, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24:652–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Sobin LH, Wittekind CH, editors. TNM classification of malignant tumors 5th edition, International Union Against Cancer (UICC). New York: Wiley; 1997. p. 59–62.Google Scholar
  16. 16.
    Solcia E, et al. Endocrine tumours of the gastrointestinal tract. In: Solcia E, Klöppel G, Sobin LH, editors. Histological typing of endocrine tumours. 2nd ed. Berlin: Springer-Verlag; 2000. p. 61–8.Google Scholar
  17. 17.
    Lawrie CH, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Peng JJ, et al. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers. World J Gastroenterol. 2007;13:3009–15.PubMedGoogle Scholar
  19. 19.
    Wang SL, et al. Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis. Mol Cell Biochem. 2008;308:93–100.CrossRefPubMedGoogle Scholar
  20. 20.
    Yan LX, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14:2348–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Shen J, et al. MicroRNAs regulate ocular neovascularization. Mol Ther. 2008;16:1208–16.CrossRefPubMedGoogle Scholar
  22. 22.
    Guglielmelli P, et al. MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol. 2007;35:1708–18.CrossRefPubMedGoogle Scholar
  23. 23.
    Wong QW, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology. 2008;135:257–69.CrossRefPubMedGoogle Scholar
  24. 24.
    Wong TS, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14:2588–92.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  • Yuanyuan Zhang
    • 1
  • Junming Guo
    • 1
  • Dong Li
    • 1
  • Bingxiu Xiao
    • 1
  • Ying Miao
    • 1
    • 2
  • Zhen Jiang
    • 1
  • Hui Zhuo
    • 1
  1. 1.Ningbo University School of MedicineNingboChina
  2. 2.Affiliated Hospital (Ningbo No. 2 Hospital)Ningbo University School of MedicineNingboChina

Personalised recommendations